A Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 written confirmation (Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 WC) is an official document issued by a regulatory agency to a Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 manufacturer, verifying that the manufacturing facility of a Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 APIs or Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 finished pharmaceutical products to another nation, regulatory agencies frequently require a Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 WC (written confirmation) as part of the regulatory process.
click here to find a list of Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571 suppliers with Written Confirmation (WC) on PharmaCompass.